Advertisement
Canada markets open in 2 hours 42 minutes

  • S&P/TSX

    21,871.96
    +64.59 (+0.30%)
     

  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     

  • DOW

    38,239.98
    +253.58 (+0.67%)
     

  • CAD/USD

    0.7297
    -0.0004 (-0.05%)
     

  • CRUDE OIL

    81.76
    -0.14 (-0.17%)
     

  • Bitcoin CAD

    90,879.23
    +321.34 (+0.35%)
     

  • CMC Crypto 200

    1,422.07
    +7.31 (+0.52%)
     

  • GOLD FUTURES

    2,317.00
    -29.40 (-1.25%)
     

  • RUSSELL 2000

    1,967.47
    +19.82 (+1.02%)
     

  • 10-Yr Bond

    4.6230
    +0.0080 (+0.17%)
     

  • NASDAQ futures

    17,407.00
    +57.00 (+0.33%)
     

  • VOLATILITY

    16.65
    -0.29 (-1.71%)
     

  • FTSE

    8,067.22
    +43.35 (+0.54%)
     

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • CAD/EUR

    0.6844
    -0.0006 (-0.09%)
     

ABcann Medicinals Inc. Announces License Renewal from Health Canada Under the Marihuana for Medical Purposes Regulations (MMPR)

ACCESSWIRE

NAPANEE, ON / ACCESSWIRE / March 26, 2015 / ABcann Medicinals Inc., is pleased to announce that it has received its license renewal from Health Canada last week. ABcann received its original license in March of 2014. This renewal signifies ABcann's commitment to compliance within the outlined Marihuana for Medical Purposes Regulations (MMPR) and to developing a highly standardized and controlled environment for the growth of medical cannabis.

ABcann began its production cycle in January 2015 with the planting of the first set of seeds. It is expected that the first batch of products will be ready for testing by late Spring 2015.

ABcann will be introducing a variety of product strains including high CBD, blended and high THC varieties. Specific THC and CBD values of the genetics will be available once the first batch of products has gone through internal and external third-party validation.

"The renewal of our license signifies our commitment to the continued development of a truly standardized medical cannabis product," states Geoff Davis, Chief Operating Officer at ABcann. "Our unique growth chambers, capable of controlling environmental factors during the growth process provide us the confidence that our medical marijuana genetics will be repeatable batch after batch."

ADVERTISEMENT

The team at ABcann is excited to see the process move forward in the coming weeks as it looks to receive approval for its remaining grow rooms. Product availability and registration dates are still yet to be determined; however clients are invited to sign-up on the website for further updates.

For more information about ABcann Medicinals Inc. please visit www.abcann.ca, email at media@abcann.ca or call at 1-855-322-2266.

ABOUT ABCANN MEDICINALS INC.

ABcann Medicinals Inc. is an approved Licensed Producer under the Marihuana for Medical Purposes Regulations (MMPR). We believe that every patient deserves access to truly standardized medical cannabis! Throughout our company and with each process built, our focus remains on creating an organic product that is safe, repeatable and reliable, time after time, because...we care.

Contact:

media@abcann.ca
1-855-322-2266

SOURCE: ABcann Medicinals Inc.